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In wound repair vimentin mediates the transition 
of mesenchymal leader cells to a myofibroblast 
phenotype
ABSTRACT Following injury, mesenchymal repair cells are activated to function as leader 
cells that modulate wound healing. These cells have the potential to differentiate to myofi-
broblasts, resulting in fibrosis and scarring. The signals underlying these differing pathways 
are complex and incompletely understood. The ex vivo mock cataract surgery cultures are an 
attractive model with which to address this question. With this model we study, concurrently, 
the mechanisms that control mesenchymal leader cell function in injury repair within their 
native microenvironment and the signals that induce this same cell population to acquire a 
myofibroblast phenotype when these cells encounter the environment of the adjacent tissue 
culture platform. Here we show that on injury, the cytoskeletal protein vimentin is released 
into the extracellular space, binds to the cell surface of the mesenchymal leader cells located 
at the wound edge in the native matrix environment, and supports wound closure. In profi-
brotic environments, the extracellular vimentin pool also links specifically to the mesenchymal 
leader cells and has an essential role in signaling their fate change to a myofibroblast. These 
findings suggest a novel role for extracellular, cell-surface–associated vimentin in mediating 
repair-cell function in wound repair and in transitioning these cells to a myofibroblast 
phenotype.
INTRODUCTION
In the normal repair process, mesenchymal cell populations restore 
tissue function in response to tissue insult or injury; however, their 
susceptibility to becoming myofibroblasts results in a response that 
promotes and sustains the fibrotic disease process. Fibrosis is a dev-
astating progressive disease, its pathology characterized by the ex-
cessive production of extracellular matrix proteins like collagen I, 
with myofibroblasts being a major producer of this fibrosis-causing 
matrix. Fibrosis affects almost every organ of the body, causing ir-
reparable damage wherever it occurs (Carver and Goldsmith, 2013). 
As fibrosis is an outcome of so many distinct disease states, it is 
considered a leading cause of death (Tsou et al., 2014).
Factors currently known to induce specific aspects of the fibrotic 
response to injury repair or pathogenesis include mechanotransduc-
tion-signaling events that involve integrin receptors, the actin cyto-
skeleton, TGFβ, and collagen I (Schwartz, 2010; Huang et al., 2012; 
Wong et al., 2012; Duscher et al., 2014; Hinz, 2015). However, it 
remains unclear how cells normally tasked with directing wound 
repair are signaled to alter their fate and differentiate to myofibro-
blasts, the cell type associated with fibrosis. Key features of myofi-
broblast differentiation include 1) high levels of expression of the 
intermediate filament protein vimentin, a mediator of cell migration 
and wound repair; 2) expression of α-smooth muscle actin (αSMA) 
and its organization into the stress fibers that mediate myofibroblast 
contractile function; and 3) production of extracellular matrix pro-
teins such as collagen I that are secreted into the extracellular milieu. 
These myofibroblast properties create an aberrant microenviron-
ment that leads to loss of tissue function.
Vimentin has emerged as a critical regulator of the wound- 
healing process in many distinct tissues and cell types. In studies of 
skin wound–repair, this protein has been demonstrated to func-
tion as a signaling integrator in tissue regeneration and healing 
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(Cheng et al., 2016). Our own studies with an ex vivo, mock-cata-
ract-surgery (MCS), epithelial wound–healing model have shown 
that vimentin is a defining characteristic of a resident mesenchymal 
“repair” cell population (Walker et al., 2010) that is located in niches 
among the cells of the lens equatorial epithelium. This mesenchy-
mal cell population is activated on wounding to immediately mi-
grate to and populate the leading edge of the injured epithelium 
(Walker et al., 2010; Menko et al., 2014a). Vimentin is required for 
the function of this mesenchymal leader cell population in directing 
the collective migration of the injured epithelium to close the wound 
(Walker et al., 2010; Menko et al., 2014a). Furthermore, we have 
found that when these cells are activated by wounding, they are also 
conferred with the ability to invade, a phenotype that is also depen-
dent on vimentin (Bleaken et al., 2016). This finding is consistent 
with other studies showing that vimentin is required for an invasive-
cell phenotype (Satelli and Li, 2011).
Here we investigate whether the properties of vimentin that con-
fer leader cells with the ability to modulate wound repair and direct 
invasion also make these cells vulnerable to environmental factors 
that can alter their differentiation pathway to that of a myofibroblast. 
Other studies have linked vimentin intermediate filaments to the 
development of fibrosis. Mice lacking vimentin have exhibited both 
reduced scarring following corneal injury (Bargagna-Mohan et al., 
2012) and a diminished fibrotic response to bleomycin-induced 
injury of the lung (dos Santos et al., 2015). However, the role of 
vimentin in inducing the fibrotic response and the specific features 
of vimentin that are associated with the fibrotic phenotype are not 
yet clear.
While long understood for their role as a highly stable, stress-
resistant cytoskeleton, vimentin intermediate filaments are now ap-
preciated as highly dynamic structures that exist in distinct assembly 
states and subcellular distributions that define their functions 
(Lowery et al., 2015; Herrmann and Aebi, 2016). The different states 
of vimentin organization range from nonfilamentous precursors to 
unit filaments to a highly organized cytoskeletal network, each with 
distinct cellular tasks (Herrmann et al., 2009; Lowery et al., 2015; 
Herrmann and Aebi, 2016). Soluble forms of vimentin are associated 
with signaling (Perlson et al., 2005), while an organized vimentin 
cytoskeletal network is critical to processes such as resisting stress 
and providing cell shape (Goldman et al., 2012). The assembly state 
of vimentin is regulated through posttranslational modifications 
(PTMs) that also modulate vimentin function. Two key PTMs linked 
to increased vimentin solubility are phosphorylation and citrullina-
tion (deimination). Some of the phosphorylation PTMs are known to 
trigger disassembly of intermediate filaments (Ando et al., 1989). 
Vimentin citrullination, which results from the conversion of an argi-
nine to a citrulline by peptidyl arginine deiminase (PAD) enzymes, 
prevents vimentin assembly and promotes vimentin filament disas-
sembly (Inagaki et al., 1989). In its soluble form, vimentin can func-
tion as an extracellular molecule that has been implicated in the 
repair process, as shown in a spinal cord injury model (Teshigawara 
et al., 2013; Shigyo et al., 2015; Shigyo and Tohda, 2016), and in 
modulating macrophage function in bacteria killing (Mor-Vaknin 
et al., 2003). In studies with our ex vivo MCS-wounded-explant cul-
tures, a model that closely replicates the features of wound repair in 
vivo, we now investigate how a resident mesenchymal repair cell 
population that modulates repair of the injured lens epithelium can 
become misdirected and become an underlying cause of the aber-
rant wound-healing response of fibrosis. We show, for the first time, 
a role for extracellular vimentin in promoting the differentiation of 
these mesenchymal repair cells to the myofibroblast phenotype 
associated with fibrosis.
RESULTS
Resident repair cells of the lens direct wounded lens 
epithelial cells to migrate off their endogenous basement 
membrane and across an adjacent tissue culture substrate
Our studies investigate how mesenchymal leader cells, whose nor-
mal role it is to direct regenerative repair of epithelia following 
wounding, can be induced to differentiate to myofibroblasts. They 
were conducted with the ex vivo MCS culture model we originally 
established to investigate mechanisms of wound repair (Walker 
et al., 2007, 2010,  2015; Menko et al., 2014a). This wound model 
has clinical relevance to fibrosis, as cataract surgery often elicits a 
fibrotic response, resulting in the disease known as posterior cap-
sule opacification (PCO) (Wormstone et al., 2009; Wormstone and 
Eldred, 2016; Nibourg et al., 2015). We focus on the resident 
population of vimentin-rich, mesenchymal repair cells of the lens 
that, on MCS injury, are activated to migrate to and rapidly popu-
late the wound edge of the lens epithelium (Figure 1A, D1 postin-
jury, repair cells at the MCS wound edge colored purple, arrow) 
(Walker et al., 2010). Here, functioning as classical leader cells, 
these cells direct regenerative repair of the injured epithelium, a 
task that is vimentin dependent (Menko et al., 2014a; Bleaken 
et al., 2016).
To create these cultures, the MCS-wounded lens is flattened on 
a tissue culture substrate by making cuts through the epithelium 
and its associated basement membrane, creating the star-shaped 
wounded-explant cultures. The cuts made to flatten the explants 
are additional injury sites that form the outside edge of the ex-
plant. These sites of injury are also rapidly populated by the 
wound-activated resident mesenchymal repair cells (Figure 1A, 
repair cells at the cut edge colored purple, arrowheads). These 
mesenchymal cells lead the lens epithelial cells from their original 
position on their native lens basement membrane capsule onto 
and across the adjacent, rigid tissue culture substrate. We refer to 
the region on the tissue culture plastic that the cells occupy post-
wounding as the extracapsular zone (ECZ). Formation of the ECZ 
in response to injury is best observed by time-lapse microscopy 
(Supplemental Video 1, representative still images shown in Figure 
1, Bi–Biii). Live imaging revealed that the mesenchymal cells at the 
leading edge extend and retract lamellipodial protrusions along 
the substrate as they lead the forward movement of the wounded 
epithelium across the culture substrate. This behavior closely par-
allels the injury response we have observed for these resident re-
pair cells previously, when they populate the leading edge of the 
MCS-wound and direct wound closure on the endogenous base-
ment membrane substrate of the lens (Menko et al., 2014a; 
Bleaken et al., 2016).
We have shown previously that vimentin is a principal charac-
teristic of the repair cells that direct wound closure at the MCS 
wound edge (Menko et al., 2014a). Here we examined whether 
vimentin was also a defining feature of the repair cells in their 
function as leader cells of the ECZ. Following immunolabeling 
for vimentin at D2 postinjury, the MCS-wounded-explant cultures 
were imaged in regions of the ECZ typical of the boxed area in 
Figure 1Biii. The leading-edge cells of the ECZ expressed high 
levels of vimentin, prominently localized to the lamellipodial 
protrusions that extend along their substrate surface (Figure 1, C 
and D, arrows). The organization of vimentin in these cells was 
examined in cultures fixed with either formaldehyde (Figure 1, C 
and E) or methanol (Figure 1, D and F), and the cells were im-
aged by both confocal (Figure 1, C and D) and superresolution 
confocal (Figure 1, E and F) microscopy. Methanol fixation, which 
extracts membrane lipids, highlighted the organized vimentin 
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cytoskeleton in the leader cell population. 
Immunostaining of formaldehyde fixed 
cultures, permeabilized with Triton X-100 
postfixation, revealed both a diffuse pat-
tern of vimentin labeling and organized 
vimentin filaments. This suggests that 
formaldehyde fixation may enhance pres-
ervation of soluble vimentin populations.
We have shown previously that another 
defining feature of the vimentin-rich, leader 
cell population activated in response to 
MCS wounding was its expression of CD44 
(Bleaken et al., 2016). While widely ex-
pressed, this cell-surface receptor for hyal-
uronic acid (HA) is characteristic of leuko-
cytes and known for its role in cell adhesion 
and migration (McDonald and Kubes, 2015; 
Bano et al., 2016; Senbanjo and Chellaiah, 
2017). Immunolabeling of the wounded-
lens explant cultures with an antibody to the 
CD44 extracellular domain at D2 postinjury 
showed that, in the ECZ, CD44 is expressed 
exclusively by the repair cells at the leading 
edge (Figure 1G, arrow). CD44 is enriched 
at the plasma membrane of these leader 
cells, especially along their cell borders (ar-
rowhead), and was not expressed by the 
lens epithelial cells that migrate behind the 
CD44+/vimentin+ leader cell population of 
the ECZ.
αSMA+ myofibroblasts appear at the 
leading edge of the ECZ, with their 
emergence linked to rigidity of the 
microenvironment
Substrate rigidity is a known factor in in-
ducing cells that mediate regenerative re-
pair to become myofibroblasts (Arora et al., 
1999; Li et al., 2007; Liu et al., 2010; 
O’Connor et al., 2015). Reprogramming of 
cells to a myofibroblast phenotype is char-
acterized by the induction of αSMA and its 
organization into stress fibers (Skalli et al., 
1989; Schmitt-Graff et al., 1994). Western 
blot analysis of protein extracts from cells 
isolated from the ECZ of MCS-wounded-
explant cultures from D1 to D6 postinjury 
showed that αSMA was first expressed by 
ECZ cells at culture D3 and increased 
greatly by D6 (Figure 2A). Since the ECZ is 
composed of both lens epithelial cells and 
the lens-resident, vimentin-rich repair cells 
that populate the wound edge postinjury, 
we performed immunofluorescence analy-
sis to determine where in the ECZ the 
αSMA-expressing cells were localized. 
Confocal image analysis at culture D3 re-
vealed that αSMA stress-fiber-positive 
myofibroblasts emerged exclusively at the 
leading edge of the ECZ (Figure 2, B and 
C), the area populated by the vimentin-rich 
FIGURE 1: Properties of leader cells activated on injury when they encounter a profibrotic 
microenvironment. (A) Ex vivo wound healing/fibrosis culture model, created by performing 
mock cataract surgery on isolated chick embryo lenses, which removes the lens fiber cell mass 
from the lens native basement membrane (BM) capsule (*). Mesenchymal repair cells (shaded 
purple) migrate to both the leading edge of the MCS wound (arrow) and to the cut edges 
created to flatten the lens capsule on the substrate (arrowhead). Repair cells at the cut edge 
lead the lens epithelium off the lens capsule onto and across the rigid tissue culture substrate, 
referred to the extracapsular zone (ECZ). (Bi–Biii) Representative still images from a time-lapse 
movie (Supplemental Video 1) taken over 3 d postinjury show the collective migration of the 
lens epithelial cells across the ECZ led by mesenchymal leader cells (arrow). The dotted white 
line in i, ii, and iii indicates the border of the native capsule and the ECZ. (C–F) Ex vivo MCS 
wounded-explant cultures were fixed in formaldehyde (C, E) or in methanol (D, F) 2 d 
postinjury, labeled for vimentin, and imaged by confocal microscopy (C, D) or superresolution 
confocal microscopy (E, F) in the ECZ, in a region similar to the boxed area in Bii. Vimentin was 
enriched in the lamellipodial protrusions extended by leader cells (C–F, arrows). When cultures 
were fixed with formaldehyde, both filamentous and diffuse populations of vimentin were 
observed at the tips of lamellipodia extensions (C, E, arrow). Methanol fixation conditions 
highlighted the vimentin cytoskeleton (D, F). (G) At 2 d postinjury the ex vivo explant cultures 
were labeled for CD44 and imaged by confocal microscopy in the ECZ. Mesenchymal leader 
cells were distinguished by their expression of the CD44 receptor (arrow), which was enhanced 
at cell borders (arrowhead). Magnification (Mag) bars = 20 µm. Images in C–G are presented as 
projections.
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FIGURE 2: Myofibroblasts emerge at the leading edge of the ECZ and their differentiation is 
influenced by the rigidity of the microenvironment. (A) Total cell lysates prepared from isolated 
ECZ regions at D1–D3, and D6 were immunoblotted for αSMA, with GAPDH as loading control. 
Results were quantified for three independent experiments and presented as a ratio of αSMA to 
GAPDH for each fraction. Results demonstrate that αSMA is first expressed on D3 and 
increases threefold by D6. (B–E, H) Ex vivo explant cultures were fixed D3 (B, C, H) and D6 
(D, E) postinjury and labeled for αSMA (B–E, H). In C, E, and H αSMA is green and F-actin is red. 
Cultures were imaged by confocal microscopy in the ECZ (B–E) or on the native capsule (H). 
αSMA-positive myofibroblasts emerged at the leading edge of the ECZ at D3 (B, C, arrows) 
and by D6 myofibroblasts had expanded in number and formed extensive αSMA stress fibers 
(D, E). (F) To examine induction of myofibroblast differentiation in a physiological relevant 
profibrotic microenvironment, the ex vivo MCS-wounded explants were cultured for 3 d 
postinjury on 2.5 mg/ml collagen gels, corresponding to 25 kPa, and immunolabeled for αSMA. 
The result shows that leader cells are induced to acquire a myofibroblast phenotype in a 
microenvironment within the physiological range of fibrotic tissues. In contrast, few αSMA+ cells 
were observed on the native capsule at culture D3 (H), at which time wound healing was just 
completed (G, white box). Results show that the rigidity of the tissue culture substrate is a factor 
in the induction of myofibroblast differentiation. The results presented represent a minimum of 
three independent studies. Mag bar = 20 µm; images in B–E and G are presented as projections. 
Image in H is presented as single optical section.
leader cells (Figure 1, C and D). The presence of myofibroblasts at 
the leading edge of the ECZ had increased greatly by D6 post-
wounding (Figure 2, D and E), in part due to their proliferation 
(Supplemental Figure 1).
We also examined whether a substrate in 
the physiological range of a profibrotic tis-
sue (Wells, 2013) induces repair-modulating 
cells to alter their fate to differentiate into a 
myofibroblast phenotype. The ex vivo, MCS-
wounded explants were placed on tissue 
culture dishes coated with collagen I gels of 
2.5 mg/ml, corresponding to a Young’s mod-
ulus of 25 kPa to examine whether rigidity of 
the microenvironment is a factor in inducing 
cells involved in repair of the wounded-lens 
epithelium to alter their fate and differenti-
ate to myofibroblasts. The stiffness of the 
collagen gel is in range of the rigidity of 
fibrotic tissues (Wells, 2013). Appearance of 
myofibroblasts in the ECZ of MCS-wounded 
explants cultured on the collagen I gel sub-
strates was determined by confocal micros-
copy imaging following immunolabeling for 
αSMA. The results show that on collagen 
gels of 25 kPa, the leading-edge cells had 
differentiated to αSMA+ stress-fiber–con-
taining myofibroblasts on D3 (Figure 2F).
The ex vivo MCS-injury model provides a 
unique opportunity to follow, concurrently, 
the function of resident repair cells in regu-
lating wound healing in their native microen-
vironment and how these same repair-mod-
ulating cells may be induced to differentiate 
to myofibroblasts in the controlled environ-
ment of the ECZ. Therefore, we examined 
whether myofibroblasts also appeared on 
the native lens basement membrane capsule 
undergoing regenerative repair post-MCS 
(Figure 2, G and H). In contrast to the induc-
tion of myofibroblasts on the ECZ substrates, 
very few αSMA+ cells were induced to form 
on the native substrate of the explant where 
the mesenchymal leader cells effectively 
direct closure of the lens epithelial wound 
by culture D3.
Resident lens mesenchymal cells 
activated to modulate repair of the 
wounded lens epithelium are 
myofibroblast progenitors
Cell fate–tracking studies were performed to 
examine whether the leader cells of the ECZ 
had the potential to become myofibroblasts. 
This approach took advantage of our ability 
to specifically tag the vimentin-rich repair 
cells at the leading edge of the ECZ with the 
extracellular domain CD44 antibody (Figure 
1G). For these studies, the mesenchymal 
leader cells were tagged with the CD44 anti-
body by live labeling for 20 min at D1 post-
injury. Then the cultures were grown through 
culture D3 when myofibroblasts first appear 
in the ECZ. To determine whether the cells labeled with CD44 at D1 
had differentiated to myofibroblasts at D3, the cultures were fixed, 
the CD44-antibody-tagged cells labeled with a fluorescent-labeled 
secondary antibody, and the cells in the ECZ coimmunolabeled for 
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FIGURE 3: CD44 positive leader cells are precursors of myofibroblasts. (A–F) ECZ cells were live 
labeled for 20 min at D1 postinjury with antibody to the cell surface antigen CD44 (A–C) or an 
isotype antibody control (D–F). (A–C) The fate of the antibody-tagged cells was followed for 2 
more days until myofibroblasts first emerge, at which point the cultures were fixed and the 
CD44-tagged cells detected with fluorescent-tagged secondary antibody, the cells colabeled for 
αSMA and imaged by confocal microscopy. (D–F) Control study in which cells were labeled with 
an isotype control antibody and then treated under the same experimental conditions as in A–C. 
(G–I) Ex vivo MCS explants were placed cell side down in the top chamber of Matrigel transwell 
invasion chambers, and the properties of the cells that had invaded to the filter side facing the 
bottom chamber determined by immunofluorescence analysis. (G) At 2 d postinjury, the 
wound-activated CD44+/vimentin+ leader cells had invaded through the Matrigel and populated 
the bottom side of the filter, confirming the efficacy of this approach to isolate the repair cell 
population. (H, I) The cells on the bottom filter were cultured through D10 postinjury and the cells 
co-immunolabeled for vimentin and αSMA. The results show that the wound-activated repair cells 
that had invaded to the bottom filter were αSMA+, demonstrating that they had acquired a 
myofibroblast phenotype. Together these studies show that the CD44+/vimentin+ leader cell 
population activated on injury are myofibroblast progenitors. A–F, Mag bar = 10 µm. G–I, Mag 
bar = 20 µm. Images shown are single optical sections (A–F, H, and I) or projections (G).
αSMA. Confocal image analysis showed that all αSMA+ stress-fiber-
expressing cells in the ECZ were positive for CD44 (Figure 3, A–C, 
arrow). As a control, the cultures were labeled with a nontargeting 
immunoglobulin G (IgG) of the same isotype as the CD44 antibody. 
The αSMA+ cells that emerge in these control cultures were not la-
beled by the nontargeting IgG (Figure 3, D–F), confirming the speci-
ficity of the CD44-tracking studies. These results demonstrate that 
the CD44+ leader cells, a vimentin-rich cell population, are progeni-
tors of the αSMA+ myofibroblasts that emerge in the ECZ in re-
sponse to wounding.
As an alternative approach, we used a 
Boyden chamber invasion assay to exam-
ine the potential of vimentin-rich repair 
cells to differentiate to myofibroblasts. We 
have previously used this assay to reveal 
the invasive properties of the CD44+/ 
vimentin+ mesenchymal subpopulation of 
the lens following their activation by MCS 
injury (Bleaken et al., 2016). For these stud-
ies, MCS-wounded-explant cultures are 
placed, cell-side down, on the Matrigel-
coated filter of the top Boyden chamber 
immediately postinjury. Serum-free me-
dium was placed in the top chamber and 
serum-containing medium in the bottom 
chamber. As shown in our previous study, 
at D2 postinjury the wound-activated 
CD44+/vimentin+ repair cells have invaded 
through Matrigel to the bottom filter sur-
face of the Matrigel-coated transwell 
chamber (Figure 3G). The wounded-lens 
epithelial cells remain associated with their 
native basement membrane capsule in the 
top chamber (Bleaken et al., 2016). The 
vimentin-rich leader cells activated follow-
ing injury that had invaded to the bottom 
of the Boyden chamber filter were fixed at 
culture D10 and immunolabeled for αSMA. 
Confocal image analysis showed that these 
cells expressed both vimentin and αSMA 
(Figure 3, H and I), evidence that the vi-
mentin+/CD44+ repair cells of the lens can 
be targeted to become myofibroblasts.
Distinct organization of actin and 
vimentin when leader cells are in 
located in proregenerative and 
profibrotic microenvironments
We found that rigidity is a factor in inducing 
wound-activated resident repair cells of the 
lens to become myofibroblasts (Figure 2). 
This suggests that the change in their differ-
entiation state involves a mechanotransduc-
tion-signaling event. The cytoskeleton is a 
key factor in transmitting mechanotransduc-
tion signals. Therefore, we compared the 
organization of the actin and vimentin cyto-
skeletons in wound-activated repair cells at 
the leading edge of the MCS wound on the 
native lens basement membrane capsule to 
their organization in the leading-edge cells 
of the ECZ that forms on the tissue-culture 
substrate. The cultures were colabeled with antibody to vimentin and 
with fluorescent-tagged phalloidin that labels F- actin. Cytoskeletal 
organization was analyzed by confocal microscopy imaging (Figure 
4, A–F). The vimentin-rich repair cells at the leading edge of the 
wound on the cells’ endogenous basement membrane capsule have 
a well-organized vimentin cytoskeleton (Figure 4, A and C, D1), but 
this leading-edge population is remarkably F-actin poor (Figure 4, B 
and C). In contrast, there is a significant population of vimentin that 
is unorganized in the repair cells at the leading edge of the ECZ, 
most highly localized to lamellipodial processes these cells extend 
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FIGURE 4: Distinct organization of vimentin and actin filaments when leader cells are in 
proregenerative and profibrotic microenvironments. (A–F) Ex vivo MCS wounded-explant 
cultures were labeled for vimentin (A, C, D, F; green in C, F) and F-actin (B, C, E, F; red in C, F) 
on day 1 (A–C) and day 2 (D–F) postinjury, and imaged by confocal microscopy. Vimentin-rich 
leader cells at the MCS wound edge on the lens native basement membrane capsule exhibited a 
highly organized vimentin cytoskeleton (A, C) but were notably poor in F-actin (B, C). In contrast, 
in leader cells associated with the profibrotic environment of the ECZ there was a prominent 
population of vimentin with a diffuse labeling pattern that was highly enriched at the tips of 
lamellipodial extensions extended along the tissue culture substrate of the ECZ, in additional to 
a more classical vimentin cytoskeletal network (D, F). These cells contained abundant F-actin 
stress fibers (E, F). (G) Solubility of vimentin was determined at the time of wounding and in the 
ECZ cells on D2 postinjury. Cells were extracted sequentially in Triton X-100/octyl glucoside 
(Triton/OG) and SDS-containing solutions to separate the soluble vimentin populations, 
including unassembled vimentin and short vimentin filaments, from the highly insoluble vimentin 
cytoskeleton. Extracts were immunoblotted for vimentin and GAPDH and the percentage of 
total vimentin (G) in each fraction was quantified over three independent experiments. Results 
show that at the time of wounding vimentin was largely a detergent-insoluble cytoskeletal 
network, in contrast to its largely soluble state of organization in the ECZ at D2 postinjury, a 
finding consistent with the diffuse state of organization of vimentin in leader cells of the ECZ at 
this time (D, F). GAPDH fractionated with the Triton/OG soluble fraction. The histogram shows 
the percentage of vimentin ± SEM. The p values were generated by Student’s t test, *p < 0.05, 
***p < 0.001. Mag bar = 20 µm. Images in A–F are presented as projections.
along the substrate surface (Figure 4, D and F, D2). In contrast to the 
MCS-wound edge, the leading-edge cells in the ECZ are rich in actin 
stress fibers (Figure 4, E and F).
Increase in vimentin solubility 
postwounding precedes leader cell 
differentiation to myofibroblasts
The diffuse vimentin-labeling pattern in the 
lamellipodia of the highly migratory repara-
tive cells at the leading edge of the ECZ 
indicated that the organization of this vi-
mentin population was distinct from the 
more classical vimentin filament structures 
in these cells. While the vimentin cytoskele-
tal network present in most cell types is in-
soluble to Triton X-100 detergent extraction 
(Osborn and Weber, 1977; Blikstad and 
Lazarides, 1983; Gilbert and Fulton, 1985; 
Soellner et al., 1985), vimentin protein that 
is not organized into filaments, or present 
in the short filament structures that often 
appear as squiggles (Chou et al., 2007), is 
Triton X-100 soluble. Using a differential de-
tergent extraction approach, we compared 
vimentin solubility in MCS-wounded ex-
plants at the time of injury to cells in ECZ at 
D2 postwounding (Figure 4G). Cells were 
extracted sequentially with a Triton X-100/
octyl glucoside buffer (Brown and Rose, 
1992) that isolates soluble forms of vimen-
tin, including unassembled unit or short vi-
mentin filaments, and a 4% SDS-containing 
buffer that extracts the highly insoluble vi-
mentin cytoskeletal network. The extracted 
proteins were separated by gel electropho-
resis and Western blotted for vimentin 
(Figure 4G). We immunoblotted for the Tri-
ton-soluble protein glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) as control. 
The Western blot results were quantified 
and represented graphically as percentage 
of total vimentin that is soluble (Triton/OG) 
and insoluble (SDS) (Figure 4G). While at the 
time of wounding, vimentin was largely 
present as a detergent-insoluble cytoskele-
tal network, at D2 postinjury in the ECZ, 
vimentin had become highly soluble, with 
the majority of the vimentin protein fraction-
ating together with GAPDH in the Triton 
X-100/OG extracts (Figure 4G). This high 
level of soluble vimentin was consistent with 
the diffuse labeling for vimentin observed in 
the leader cell population of the ECZ (see 
Figure 4D).
Posttranslational modification of 
vimentin following injury
We investigated the possibility that post-
translational modifications (PTMs) of vimen-
tin linked to vimentin solubility, including 
citrullination and phosphorylation (Ando 
et al., 1989; Inagaki et al., 1989; Sihag et al., 
2007; Hyder et al., 2008; Snider and Omary, 
2014; Gudmann et al., 2015), were associated with the repair-mod-
ulating leader cell population activated by MCS injury. The pres-
ence of citrullinated proteins in MCS-wounded-explant cultures 
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vimentin and citrulline and then the cultures 
were labeled for F-actin with fluorescent-
conjugated phalloidin. A positive PLA signal 
(red) was detected in the lamellipodia tips of 
the leading-edge cells of the ECZ, shown at 
two levels of magnification. Mag bars, C–H, 
and low-magnification image in I = 20 µm. In 
high-magnification images in I the Mag bar = 
10 µm; images are presented as projections.
FIGURE 5: Citrullinated vimentin is detected postinjury and associated with repair-modulating 
leader cells. (A) Proteins from D2 MCS-wounded-explant cultures were extracted, 
immunoprecipitated with a citrulline antibody, and immunoblotted for vimentin. The results 
showed the presence of vimentin in these citrulline immunoprecipitates. Whole cell lysates 
(WCL) of MCS-wounded explants were immunoblotted for vimentin as a control. (B) Lysates of 
cells in the ECZ regions at D2 postwounding were immunoblotted for citrulline and reprobed for 
vimentin. Results shown for two independent studies (ECZ1 and ECZ2) demonstrate that 
vimentin comigrates with the principal citrullinated band at 55 kDa (arrow), supporting the 
conclusion that vimentin is citrullinated in cells of the ECZ. GAPDH is shown as a loading control. 
(C–H) MCS-wounded explant cultures were coimmunolabeled at D2 postinjury with antibodies 
to citrulline (C, E, F, H) and vimentin (D, E, G, H). The cultures were imaged in the ECZ by 
confocal microscopy (C–E), and at the leading edge of the same ECZ by superresolution 
confocal microscopy (F–H). While citrullinated proteins localized throughout the ECZ, they were 
enriched in leading edge cells, including many regions where citrulline colocalized with vimentin. 
(I) Proximity ligation assay (PLA) was performed in the ECZ at 2 d postinjury with antibodies to 
was examined using an immunoprecipita-
tion approach. At 2 d postinjury, protein 
extracts were immunoprecipitated with an-
tibody to citrulline and the immunoprecipi-
tated, citrullinated proteins immunoblotted 
for vimentin (Figure 5A). The results showed 
that vimentin is present in these citrulline 
immunprecipitates, indicating that vimentin 
is citrullinated in the MCS-wounded-ex-
plant cultures. Next, we extracted the pro-
teins from the ECZ region at D2 postinjury, 
electrophoretically separated the proteins, 
immunoblotted the ECZ extracts for the ci-
trulline PTM, and reprobed for vimentin 
(Figure 5B). This study demonstrated the 
citrullinated protein of greatest abundance 
migrated at 55 kDa and was labeled with 
antibody to vimentin; this supports the con-
clusion that vimentin is citrullinated in cells 
that form the ECZ postwounding.
Next, cell-based studies were performed 
to examine the localization of citrullinated 
proteins in ECZ region at D2 postwounding. 
The cultures were coimmunolabeled for ci-
trulline and vimentin (Figure 5, C–H). While 
there are citrullinated proteins throughout 
the ECZ, they are enriched in the cells at the 
leading edge (Figure 5, C–E). Superresolu-
tion confocal imaging of the protrusions 
extended along the substrate by the leader 
cells of the ECZ showed coincident immu-
nolabeling of citrulline with a subset of the 
vimentin protein in these cells (Figure 5, 
F–H). To further examine vimentin citrullina-
tion in the lamellipodial protrusions of the 
leader cells in the ECZ we performed a 
proximity ligation assay (PLA) with antibod-
ies to vimentin and the citrulline PTM and 
postlabeled the cells for F-actin. The results 
showed a strong vimentin/citrulline PLA sig-
nal specific to the cells at the leading edge 
of the ECZ (Figure 5I).
Another PTM associated with vimentin 
solubility is its phosphorylation at sites 
such as Ser38. Immunolabeling for pSer38- 
vimentin at D2 post-MCS wounding showed 
that pSer38-vimentin+ cells were associated 
with cells remaining on the wounded ex-
plant but that there were very few pSer38-
vimentin+ cells at the leading edge of the 
ECZ (Supplemental Figure 2). As there are 
multiple potential sites for vimentin phos-
phorylation, phosphorylation PTM cannot 
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be ruled out as a factor in regulating vimentin organization and func-
tion in the leader cells of the ECZ.
On injury extracelluar vimentin is released into the 
extracellular space and associated with the surface of 
wound-activated leader cells and their underlying matrix 
substrate
Although best known as a component of the intermediate filament 
cytoskeleton, vimentin has also been shown to function as an extra-
cellular protein. In this form, vimentin binds to the cell surface at 
distinct sites, including specific cell-surface receptors, where it initi-
ates a cellular response (Garg et al., 2006; Shigyo et al., 2015). 
Among the roles identified for extracellular vimentin are the regula-
tion of 1) immune cell function (Mor-Vaknin et al., 2003), 2) viral/
bacterial entry into cells (Koudelka et al., 2009; Chi et al., 2010; Das 
et al., 2011; Liang et al., 2011; Du et al., 2014; Mak and Brugge-
mann, 2016; Yu et al., 2016), and 3) tumor progression (van Beijnum 
et al., 2006; Satelli and Li, 2011). In studies with our clinically rele-
vant MCS-injury model, we examined whether extracellular vimentin 
was also a factor in the tissue response to wounding. We began with 
an immunoblot analysis of conditioned media collected from the 
MCS-wounded-explant cultures at D1 postinjury, which showed that 
on injury vimentin was released into the culture media during the 
repair process (Figure 6A). Medium alone does not contain vimen-
tin. Since in a previous study we found no evidence of cell death 
following MCS (Walker et al., 2010), we considered this an unlikely 
source of the vimentin released into the medium. Terminal deoxy-
nucleotidyl transferase dUTP nick end labeling (TUNEL) assay analy-
sis performed at D1 postinjury showed that very few cells were 
TUNEL positive in the MCS-wounded-explant cultures (Supplemen-
tal Figure 3), supporting this conclusion. These findings imply that 
the release of vimentin into the media is an active process of the 
wounding-healing response.
The impact of extracellular vimentin on cell behavior following 
wounding is expected to involve its association with the cell surface. 
To determine whether vimentin is on the surface of cells, we labeled 
the cells within the ECZ with a cell-impermeable biotinylation re-
agent at D2 postwounding. Labeling with fluorescent-conjugated 
streptavidin, which directly binds to biotin, confirmed that the biotin 
label in this study was limited to the cell surface (Figure 6B). Follow-
ing biotinylation, the ECZ cells were extracted and their biotin-
tagged surface proteins isolated on an avidin column. The isolated, 
biotin-tagged proteins were immunoblotted for vimentin (Figure 
6C), for the surface receptor N-cadherin (positive control), and for the 
cytoplasmic proteins GAPDH and Akt (negative controls) (Figure 6C). 
The results showed that extracellular vimentin was linked to the sur-
face of cells in the ECZ. Cell-surface-linked vimentin may associate 
directly with the cell surface as it is released from the cells or become 
associated with the cell surface after it is released to the medium.
To determine whether there was cell-type specificity of vimentin 
cell-surface association, MCS-wounded-explant cultures were fixed 
with paraformaldehyde and not permeabilized prior to immunola-
beling for vimentin. We examined both the MCS wound edge on 
the native basement membrane capsule (Figure 6E) and the leading 
edge of the cells migrating across the ECZ (Figure 6F) by confocal 
imaging for the presence of cell-surface–associated vimentin. The 
results show that extracellular vimentin was bound exclusively to the 
wound-activated repair cells at the leading edge of both the MCS 
wound and the ECZ. Z-stacks collected at high magnification in the 
ECZ revealed that extracellular vimentin was widely distributed all 
along these cells’ basal surfaces, with higher levels at the filopodia/
lamellipodial processes extended at the cells’ periphery (Figure 6H). 
At these cells’ apical domains, extracellular vimentin was mostly 
located to the surface of the filopodia/lamellipodial processes 
extended between the cells (Figure 6G).
Using a biochemical approach, we investigated if vimentin re-
leased in response to wounding was associated with matrix substrate 
underlying the leader cells in the ECZ. For this study, the wounded 
explants were detached from the tissue culture substrate and the 
ECZ cells removed by gentle scraping at D2 postinjury, leaving be-
hind proteins linked to the substrate surface of the ECZ. These sub-
strate-associated proteins were extracted and immunoblotted for 
vimentin, which was shown to be a component of this protein frac-
tion (Figure 6I). Immunoblotting for GAPDH confirmed that these 
substrate-associated extracellular lysates were largely cell free. In 
parallel, extracts from the wounded explants that were detached 
from the dish were immunoblotted for vimentin and GAPDH. In a 
different approach, the cells in the ECZ were exposed to the mem-
brane-impermeable cross-linker bis (sulfosuccinimidyl) suberate (BS3) 
at D2 postinjury to link cell-surface–associated proteins to proteins in 
their ECM microenvironment. After radioimmunoprecipitation assay 
(RIPA) buffer extraction of cellular proteins the extracellular proteins 
were coimmunolabeled for vimentin and the ECM protein tenascin-
C that forms a provisional matrix on the underlying substrate of ECZ 
cells migrating in response to wounding. Tenascin-C has been impli-
cated in the induction of fibrosis (Kasprzycka et al., 2015; Bhattacha-
ryya et al., 2016; Fu et al., 2017). Confocal imaging showed codistri-
bution of tenascin-C and vimentin on the substrate surface in an area 
underneath the leader cells of the ECZ (Figure 6, J and K). No F-actin 
was detected in these cross-linking/extraction studies (Figure 6L).
Extracellular vimentin signals leader cell behavior in 
response to wounding and the differentiation of these 
cells to a myofibroblast phenotype
Our results showed that a soluble, extracellular, vimentin pool was 
released by the cells into the culture medium during the repair pro-
cess, so we examined whether the timing of myofibroblast emer-
gence could be enhanced by the addition of soluble vimentin into 
the explant culture medium. Those results showed that increasing 
the concentration of vimentin over that produced by the cells did 
not alter the timing of myofibroblast emergence or significantly alter 
the degree of myofibroblast induction in this clinically relevant 
wound-repair culture model (Supplemental Figure 4). Therefore, we 
examined the functional roles of extracellular vimentin produced by 
the cells in response to MCS wounding in both wound repair and 
the induction of fibrosis. For these studies, the wounded cultures 
were grown in the presence of monoclonal antibodies to vimentin. 
To analyze effects on wound closure and emergence of myofibro-
blasts, we used two distinct vimentin antibodies, AMF17B and H5, 
with IgG of the same isotype as control. In our previous studies, we 
have shown that wound closure on the native substrate of the base-
ment membrane capsule is typically complete by D3 post-MCS 
(Menko et al., 2014a,b). For these studies, antibodies to vimentin 
were added to the explant cultures at the time of wounding (D0), 
the cultures imaged daily through culture D3, and open-wound area 
quantified. Wound repair in the presence of the vimentin antibodies 
slowed wound closure (Figure 7A), with dynamics and phenotype 
similar to what we observed previously with small interfering RNA 
vimentin knockdown (Menko et al., 2014a).
To investigate whether extracellular vimentin regulates leader 
cell function in the ECZ and signals differentiation of leader cells to 
myofibroblasts, we exposed the cells in the ECZ to antibodies to 
vimentin from D1 postinjury, after removing the original lens ex-
plants from the culture dish, and examined them for effects on 
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leader cell behavior and emergence of myofibroblasts at D3 in 
culture. Both vimentin antibodies suppressed the extension of 
lamellipodial processes by the leader cells and interfered with the 
movement of leader cells across the ECZ (Figure 7B). The H5 mono-
clonal antibody (mAb) had a more potent effect on lamellipodia ex-
tension than AMF17B. Biochemical analysis revealed that blocking 
the extracellular vimentin signal inhibited expression of the myofi-
broblast protein αSMA by cells in the ECZ, with H5 being slightly 
more efficacious at blocking αSMA expression than AMF17B (Figure 
7C). Immunolabeling confirmed that these vimentin antibodies sup-
pressed the differentiation of leader cells to αSMA+ myofibroblasts 
(Figure 7, E and F and H and I). The isotype IgG control had no ef-
fect on either cell migration or the development of fibrosis (Figure 7, 
D and G). We also treated the ex vivo MCS cultures with low doses 
of Withaferin A (WFA), which targets vimentin-soluble pools to in-
hibit vimentin function (Bargagna-Mohan et al., 2013) but can also 
have off-target effects (Vanden Berghe et al., 2012). We found that 
WFA, added to the media at D1 postinjury, decreased soluble pools 
of vimentin, altered the motility of the leader suppressing the exten-
sion of lamellipodial protrusions along the substrate surface, and 
blocked emergence of αSMA+ myofibroblasts in a dose-dependent 
manner (Supplemental Figure 5). Together, these studies show that 
the extracellular population of vimentin has the potential to regulate 
leader cell function in the repair process and to signal their differen-
tiation to myofibroblasts.
DISCUSSION
Fate of mesenchymal repair cells is determined by their 
microenvironment
In studies of wound repair, there is growing evidence that mesen-
chymal cell populations activated to direct regenerative repair 
become the progenitors of the myofibroblasts that underlie the ab-
errant repair processes of fibrosis and scarring. We have discovered 
that the cytoskeletal protein vimentin, which is essential to the nor-
mal function of these repair-modulating cells in tissue regeneration, 
can tip the balance from regenerative to fibrotic repair when these 
cells encounter a profibrotic microenvironment. Our studies exam-
ined this dichotomous role for repair cells in the clinically relevant ex 
vivo MCS wound-repair/fibrosis culture model. In their native micro-
environment of the lens basement membrane capsule, these vimen-
tin-rich mesenchymal repair cells rapidly migrate to the leading 
edge of the MCS wound where they direct lens epithelial tissue 
repair in a vimentin-dependent manner. When these same repair 
cells move to the outside edges of the MCS explant cut to flatten 
the lens capsule on the substrate, they lead lens-epithelial cells off 
the lens capsule onto and across the culture dish, where these 
vimentin-rich leader cells are induced to differentiate to αSMA+ 
myofibroblasts, the cell type associated with fibrotic disease. This 
same change in cell phenotype was induced when these repair cells 
encounter a collagen gel microenvironment whose stiffness is in the 
physiological range of fibrotic tissues.
Cell-surface–associated vimentin is a factor in determining 
repair cell fate and function
In our wound healing/fibrosis model, using vimentin antibodies 
that blocked the function of extracellular vimentin, we found that 
vimentin plays a role in promoting fibrosis beyond its classically 
described structural functions. Our studies show for the first time 
that an extracellular, cell-surface–associated vimentin population 
released in response to injury is linked specifically to the wound-
activated mesenchymal repair cells that localize to the leading 
edge of the MCS wound. This extracellular vimentin pool is required 
for the function of these mesenchymal leader cells in directing the 
regenerative repair process in the cells’ native basement mem-
brane microenvironment (modeled in Figure 8). Our data suggest 
that the fate of these cells is altered to that of a myofibroblast 
when they associate with a profibrotic ECM microenvironment. This 
interaction has the potential to signal a change in cell fate to a 
myofibroblast and alter the function of these repair cells from pro-
regenerative to agents that promote fibrotic disease. It is possible 
that this extracellular vimentin population functions by binding to a 
putative receptor for extracellular vimentin located on the cell 
surface of the repair cells.
Corrleation between vimentin solubility and citrullination 
following injury
A high percentage of the vimentin pool in the cells of the ECZ 
following wounding was Triton/OG detergent soluble, contrasting 
the highly detergent-insoluble vimentin cytoskeletal network of the 
lens before wounding. Detergent insolubility is a feature of this 
intermediate filament protein typical of most cell and tissue types 
(Osborn and Weber, 1977; Blikstad and Lazarides, 1983; Gilbert and 
Fulton, 1985; Soellner et al., 1985). It is likely that the soluble pool 
of vimentin in the ECZ includes both cytoplasmic and extracellular 
forms of this protein. Our data suggest that maintaining a large, 
soluble pool of vimentin in response to the MCS wound is important 
to the mechanism by which the mesenchymal leader cells function 
in directing regenerative repair.
Vimentin solubility is typically associated with PTMs of this pro-
tein, with both citrullination and phosphorylation believed to be 
primary PTMs that lead to and/or maintain vimentin protein-soluble 
states (Ando et al., 1989; Inagaki et al., 1989; Sihag et al., 2007; 
Hyder et al., 2008; Snider and Omary, 2014). Our studies show that 
vimentin citrullination was a feature of the mesenchymal leader 
cells located at the leading edge of the cells migrating across the 
ECZ. This finding is interesting in light of evidence that suggests 
citrullinated forms of vimentin play a role in fibrosis, including a re-
port that patients with fibrosis express PAD enzymes that catalyze 
vimentin citrullination (Abdeen and Olusi, 2010; Gudmann et al., 
2015) and the finding that patients with fibrosis produce antibodies 
to citrullinated vimentin (Abdeen et al., 2011; Vassiliadis et al., 
2012, 2013).
Dynamic differences in vimentin and actin cytoskeletal 
organization in proregenerative and profibrotic 
environments
The lamellipodial protrusions that the mesenchymal leader cells ex-
tend along the rigid substrate of the ECZ were rich in vimentin, with 
a high level of the vimentin labeling of these cells appearing diffuse. 
This immunolabeling pattern likely represents a concentration of 
soluble forms of vimentin, which could include unassembled vimen-
tin protein, and unit or short vimentin, likely including vimentin that 
is released to their cell surface. A distinguishing feature of the mes-
enchymal repair cells is the assembly of actin stress fibers in the 
more rigid ECZ microenvironment, but not when these cells popu-
late the MCS wound edge on their native basement membrane. It 
has been shown that the presence of an organized vimentin inter-
mediate filament cytoskeletal network can negatively regulate Rho 
activity and block both actin stress fiber formation and myosin con-
tractility (Jiu et al., 2017). This suggests that there is a dynamic, 
coordinated regulation of cytoskeletal elements in these cells and 
indicates that the predominance of soluble vimentin forms may 
be necessary to establish the contractile phenotype of αSMA+ 
myofibroblasts.
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FIGURE 6: Extracellular vimentin is released in response to injury, associated with the cell surface of leader cells and 
localized along the ECM substrate beneath the cells. (A) Conditioned media was collected from ex vivo MCS cultures at 
1 d postinjury and immunoblotted for vimentin. The results show that an extracellular form of vimentin is released in the 
media. No vimentin is present in culture media prior to exposure to the cells. (B) Cell surface proteins in the ECZ were 
biotinylated at culture D2 and fixed and the biotin label was tagged with fluorescent-conjugated streptavidin. The 
results showed that biotin labeling is restricted to the cell surface of cells in the ECZ. (C) Cell surface proteins in the ECZ 
were biotinylated at culture D2, extracted, and immunoblotted for vimentin, N-cadherin (positive control), and GAPDH 
and Akt (negative controls). The results demonstrated that extracellular vimentin is associated with the surface of cells in 
the ECZ. (D–H) Paraformaldehyde fixed but not permeabilized ex vivo wounded cultures were immunolabeled for 
vimentin to examine cell type specificity for extracellular-surface–associated vimentin at both the MCS wound edge 
(D, arrow) and the leading edge of the ECZ (D, arrowhead). Cell-surface vimentin localized exclusively to leader cells of 
both the native BM capsule (E) and in the ECZ (F). Boxed region in F is shown at higher magnification along apicolateral 
(G) and basal (H) aspects of the cells. While extracellular vimentin was most prominent on cellular protrusions at the 
apicolateral surface of the leader cells in the ECZ, the extracellular vimentin pool localized all along the cells’ basal 
surfaces of these cells where they contact the extracellular matrix and to basal membrane extensions between cells. 
(I) To determine whether basal extracellular vimentin also was associated with the substrate beneath the cells, cell-free 
extracts of substrate-associated proteins were examined by Western blot. Extracts of isolated ex vivo explants were 
included as a control (WCL). Results show that extracellular vimentin is associated with the proteins on the substrate. 
Immunoblotting for GAPDH confirmed that extracellular lysates were largely cell free. Results are representative of 
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On injury vimentin is released into the extracellular space
Our discoveries that extracellular vimentin is released in these 
wound-repair cultures in response to injury, that it associates with 
the cell-surface of repair-modulating cells, and that it mediates the 
differentiation of the leader/repair cells to myofibroblasts are im-
portant new findings. The mechanism of vimentin release is not yet 
clear. While vimentin lacks a classic secretory signal sequence, it is 
secreted by macrophages in response to both pro- and anti-inflam-
matory cytokines (Mor-Vaknin et al., 2003). The release in exosomes 
is another potential source for the extracellular vimentin pool (Chen 
et al., 2016). Our own studies of the invasive potential of these 
wound-activated repair cells have shown that when these cells 
migrate through three-dimensional Matrigel, they are surrounded 
by vimentin concentrated in puncta that could represent vimentin-
containing vesicles (Bleaken et al., 2016).
Potential mechanisms of extracellular vimentin function
While extracellular vimentin has been localized to the cell surface of 
different cell types, including macrophages (Mor-Vaknin et al., 
2003), endothelial cells (Xu et al., 2004; Zou et al., 2006; Koudelka 
et al., 2009; Glaser-Gabay et al., 2011), neutrophils (Moisan and 
Girard, 2006), astrocytes (Teshigawara et al., 2013), and circulating 
tumor cells (Satelli et al., 2014, 2016, 2017), its extracellular function 
has been poorly understood. In the mesenchymal repair cells that 
populate the leading edge of the ECZ of our MCS-wounded cul-
tures, extracellular vimentin was most highly localized to the cells’ 
basal surfaces (see model, Figure 8). Vimentin could mediate signal-
ing binding to cell-surface receptors, transmitting a mechanotrans-
duction signal that leads to the change in cell fate associated with 
fibrosis. In support of this hypothesis, studies have reported that vi-
mentin can act as a ligand for cell-surface receptors, such as CD44 
(Pall et al., 2011) and IGF-1R (Garg et al., 2006; Shigyo et al., 2015). 
While future studies will be aimed at elucidating the mechanisms by 
which extracellular vimentin signals myofibroblast differentiation, 
our current studies show that the microenvironment is a critical 
driver of the function of the extracellular pool of vimentin. In wound 
repair, the microenvironment determines whether vimentin associ-
ated with the surface of the mesenchymal cells activated on wound-
ing promotes their role in regenerative repair or their transition to 
myofibroblasts associated with fibrosis.
MATERIALS AND METHODS
Ex vivo MCS explant cultures
Ex vivo MCS explant cultures were prepared as previously described 
(Walker et al., 2007, 2010, 2015; Menko et al., 2014a,b). Cells were 
cultured in complete media (Media 199) (Invitrogen, Carlsbad, 
CA) that included 1% penicillin/streptomycin (Mediatech-Cellgro, 
Manassas, VA), and 1% l-glutamine (Mediatech-Cellgro) with 10% 
fetal calf serum (Invitrogen). The mock cataract surgery is performed 
after lenses are removed from E15 chick embryos (Poultry Futures, 
Lititz, PA) to ex vivo culture. This microsurgical procedure removes 
the fiber cells that comprise the mass of lens tissue (Walker et al., 
2007, 2015), leaving the basement membrane that surrounds the 
lens in vivo as a capsular bag structure containing only the wounded 
lens epithelial cells and a subpopulation of vimentin-rich mesenchy-
mal repair cells (Walker et al., 2010; Menko et al., 2014a). The lens 
epithelium and subpopulation of mesenchymal repair cells associ-
ated with the lens capsule are placed on tissue plastic cell side up. 
By making cuts in the anterior aspects of the lens capsule, we flatten 
the postcataract surgery lens capsular bag with its lens epithelial 
and mesenchymal repair cells still attached. The resultant star-
shaped, flattened explants are placed on the culture dish, cell side 
up (Figure 1A). The wounded lens epithelial cells are located at the 
points of the star, surrounding the denuded lens capsule in the 
center of the explants where the fiber cells had been attached 
(Figure 1A, asterisk).
Since differentiation to myofibroblasts is promoted in a rigid ex-
tracellular environment (Tomasek et al., 2002; Hinz, 2007; Carver 
and Goldsmith, 2013), we studied myofibroblast emergence in cells 
that migrate from the outside cut edges of the ex vivo MCS-
wounded-explant cultures onto and across the rigid microenviron-
ment of the tissue culture plastic (Figure 1, A and B). The lens 
epithelial cells are led off the lens capsule by vimentin-rich mesen-
chymal cells that had rapidly migrated to the outside cut edge of 
the capsule in response to the cut wound. We refer to the region just 
beyond the lens capsule as the ECZ, the cells of which provide an 
ideal reductionist model with which to study how cells critical to 
regulating injury repair can be induced to change their fate and 
become the myofibroblasts that underlie fibrosis.
For collagen gel substrate studies, MCS-wounded-explant cul-
tures were placed directly on tissue culture dishes coated with 1 ml 
of 2.5 mg/ml rat tail collagen I gels, according to the manufacturer’s 
instructions (Millipore, Billerica, MA).  For Boyden Chamber invasion 
studies, MCS-wounded-explant cultures were placed cell side down 
on Matrigel-coated membrane filters in Matrigel-Transwell assays 
(BD Biosciences, San Jose, CA, and Corning, Corning, NY). Serum-
free media was placed in the upper chamber and serum-containing 
medium to the lower chamber. The underside of the filters contain-
ing invaded cells was processed for immunostaining. Phase images 
were acquired with a Nikon Eclipse Ti microscope using imaging 
software (NIS Elements; Nikon). Time-lapse video was acquired us-
ing a Nikon Eclipse Ti microscope driven by image analysis software 
(NIS Elements). For time-lapse studies the culture dishes were con-
tained in a Tokai Hit stage-top incubator. Vimentin function was 
blocked with vimentin monoclonal antibodies, H5 (10 µg/ml) or 
AMF17b (20 µg/ml) (mAbs; Developmental Studies Hybridoma 
Bank, Bank Iowa City, IA), with mouse IgG isotype antibody (20 µg/
ml) from Jackson Immunoresearch Laboratories (West Grove, PA) as 
control. In supporting studies vimentin was blocked with the 
0.5–1 µM Withaferin A (Tocris, Ellisville, MO) with the vehicle di-
methyl sulfoxide (DMSO; Sigma Aldrich, St. Louis, MO) as control. 
Fresh antibody or inhibitor was added each day. To determine the 
effect of exogenous vimentin on myofibroblast differentiation, re-
combinant vimentin (catalogue no. 2105-VI-100 from R&D Systems, 
Minneapolis, MN) was added to ex vivo cultures on day 1. For 
proliferation analysis, cells were pulsed with EdU (Click-iT EdU 
Imaging Kits; Invitrogen, Carlsbad, CA) for 2 h and analyzed accord-
ing to the manufacturer’s instructions. TUNEL assay (catalogue 
three independent experiments. (J–L) To directly view the substrate-linked extracellular vimentin, extracellular proteins 
in the ECZ were cross-linked with the membrane-impermeable BS3 cross-linker, cells extracted with RIPA, and the 
cross-linked proteins fixed and labeled for tenascin-C (TN-C; J), vimentin (K), and F-actin (L). The results show that 
extracellular vimentin was associated with the extracellular matrix substrate organized beneath the leader cells of the 
ECZ (J, K). No staining for F-actin was detected in the cross-linked/extracted cultures (L) confirming effective removal of 
the cells. Mag bars B, E = 20 µm; F = 50 µm; G, H, J–L = 10 µm. Images in B, E, F, G, and H are presented as single 
optical sections. Images in J–L are presented as projections.
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FIGURE 7: Extracellular vimentin mediates leader cell behavior associated with wound healing 
and their transition to myofibroblasts. To examine the role of extracellular vimentin in both 
wound repair and fibrosis, the MCS-wounded-explant cultures were grown in the presence of 
two distinct antibodies to vimentin, AMF7b, and H5 or in the presence of a nontargeting IgG of 
the same isotype as control. (A) For the wound-healing studies, the MCS explants were treated 
with the vimentin antibodies from the time of wounding (D0) through D3, by which time the 
wound is typically healed. Open wound area was quantified each day and the results presented 
graphically. Representative phase-contrast images are shown at culture D3 (double arrow 
indicates open wound area). The presence of either vimentin antibody during wound-repair 
slowed wound closure. (B–I) Isolated ECZ regions were exposed to the vimentin antibodies 
(AMF17b and H5) or IgG isotype control for 2 d beginning at D1 postinjury to determine the 
effect of blocking extracellular vimentin function on myofibroblast emergence. (B) Phase-
contrast imaging showed that lamellipodia extension at the leading-edge of the ECZ was 
impaired by treatment with either the AMF17B or the H5 vimentin antibodies (see arrows). 
(C) Total cell lysates prepared from ECZ regions exposed to AMF17B, H5, or isotype control 
antibodies were immunoblotted for αSMA and GAPDH, the results quantified and presented as 
a ratio of αSMA to GAPDH. This study showed that exposure to either of the vimentin 
antibodies inhibited emergence of αSMA+ myofibroblasts. (D–I) ECZ cells were treated with 
either the vimentin antibody AMF17b, the vimentin antibody H5, or an isotype-specific IgG 
beginning at D1 postinjury and fixed at culture D3. The cultures were immunolabeled for αSMA 
(D–I, red in G–I) and colabeled for F-actin (G–I, green). Emergence of αSMA+ myofibroblasts at 
the leading edge of the ECZ was inhibited by 
blocking extracellular vimentin function. 
p values generated by Student’s t test 
***p < 0.001. Mag bar B = 10 µm and D–I = 
20 µm. Images in D–I are presented as 
projection images.
no. 12156792910) from Sigma Aldrich (St. 
Louis, MO) was performed according to the 
manufacturer’s instructions.
Sequential detergent extraction
As we have described previously (Leonard 
et al., 2011; Menko et al., 2014a), for se-
quential extraction studies samples were 
extracted with Triton X-100/octyl glucoside 
(Triton/OG) extraction buffer (44.4 mM n-
octyl β-d-glucopyranoside, 1% Triton X-100, 
100 mM NaCl, 1 mM MgCl2, 5 mM EDTA, 
10 mM imidazole, pH 7.4). The Triton/OG-
insoluble proteins were solubilized in 2× 
sample buffer (125 mM Tris-HCl, 4% SDS, 
20% glycerol, 2% β-mercaptoethanol, 0.5% 
bromophenol blue). To determine the rela-
tive distribution of Triton/OG soluble and 
insoluble proteins the Triton/OG soluble 
fractions were loaded at equal protein con-
centration and the SDS fractions were 
loaded at volumes equal to the respective 
Triton/OG soluble fractions.
Western blot analysis
Samples were extracted in Triton/OG except 
for studies of α-SMA expression for which 
the cells were extracted in RIPA buffer (5 mM 
EDTA, 150 mM NaCl, 1% NP40, 1% sodium 
deoxycholate, 1% SDS 20% solution, 50 mM 
Tris-HCl, pH 7.4) containing protease/phos-
phatase inhibitor cocktail (Cell Signaling, 
Danvers, MA). All protein concentrations 
were determined by a BCA protein assay 
(BCA Assay; Pierce, Rockford, IL). All proteins 
were separated on Tris-glycine gels (Novex, 
San Diego, CA), under reducing conditions 
followed by electrophoretically transferring 
to membranes (Immobilon-P; Millipore), and 
subsequently immunoblotted as described 
previously (Walker and Menko, 1999). En-
hanced chemiluminescence (ECL) and ECL 
Plus Western blotting substrate (Pierce; Ther-
moFisher, Waltham, MA) were used for de-
tection. Antibodies used for Western blot-
ting (see Table 1) included vimentin (AMF17b 
mAb; Developmental Studies Hybridoma 
Bank, Iowa City, IA), vimentin polyclonal anti-
body (a generous gift from Paul FitzGerald, 
University of California, Davis, CA), GAPDH 
(catalogue no. sc-25778) from Santa Cruz 
Biotechnology (Santa Cruz, CA), α-smooth 
muscle actin (catalogue no. ab5694) from 
Abcam (Cambridge, United Kingdom), 
N-cadherin (catalogue no. 610921) from BD 
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FIGURE 8: Model depicting differences in vimentin and actin cytoskeleton organization in mesenchymal leader cells in 
proregenerative and profibrotic environments. The mesenchymal leader cells that locate to the wound edge in a 
proregenerative environment organize an extensive vimentin intermediate filament cytoskeleton that extends into the 
cells’ lamellipodial processes. These repair-modulating cells are remarkably poor in actin stress fibers. The cytoskeletal 
organization is altered when these mesenchymal leader cells migrate into a profibrotic environment. Here, these cells 
organize extensive actin stress fibers and vimentin is most striking for its high expression in the cells’ lamellipodia where 
it is present in a diffusely organized form. On injury, vimentin is also released to the extracellular space and becomes 
linked to the cell surface of the mesenchymal repair cells at the leading edge of both environments where it plays a role 
in both wound repair and altering these cells’ fate to myofibroblasts.
Antibody name Source Product number Dilution factor
Alpha smooth muscle actin Millipore Sigma CBL171 1/200 (IF)
Alpha smooth muscle actin Abcam Ab5694 1/100 (IF); 1/1000 (WB)
Akt Cell Signaling 9272 1/1000 (WB)
CD44 Developmental Studies Hybridoma Bank (DSHB) 1D10 1/10 (IF)
Citrulline Abcam Ab6464 1/100 (IF)
Citrulline Millipore Sigma MABN328 1/200 (IF); 1/500 (WB)
GAPDH Santa Cruz Sc-25778 1/1000 (WB)
N-cadherin BD Transduction Lab 610921 1/2000 (WB)
Tenascin Millipore Sigma AB19013 1/200 (IF)
Vimentin DSHB AMF17B 1/10 (IF); 1/100 (WB)
Vimentin DSHB H5 1/10 (IF)
Vimentin Abcam Ab92547 1/2500 (WB)
Vimentin (phosphoS38) Abcam Ab52942 1/100 (IF)
Vimentin Gift, Paul FitzGerald, University of California, Davis 1/100 (IF)
TABLE 1: Antibody sources, product numbers, and dilutions used in these studies.
Biosciences (San Jose, CA) and Akt (catalogue number 9272) from 
Cell Signaling (Danvers, MA). Densitometry analysis was performed 
using AlphaView Software (Protein Simple; San Jose, CA). α-SMA 
expression in the time course is presented as a ratio to GAPDH. For 
the WFA and vimentin antibody studies results were normalized to 
control and presented as a ratio to GAPDH. Sequential detergent 
extractions are shown as the percentage of total vimentin in each 
fraction. Histograms are shown ± SEM, with p values generated by 
Student’s t test.
Cell-surface biotinylation
For biotinylation of cell-surface proteins we used the Cell Surface 
Protein Isolation Kit (Pierce; ThermoFisher, Waltham, MA) accord-
ing to manufacturer’s directions. Briefly, cells were incubated with 
the membrane-impermeable Sulfo-NHS-SS-Biotin reagent. After 
the reaction was stopped, cells were gently scraped, lysed, and 
transferred to a NeutroAvidin agarose column for isolation of 
biotin- labeled cell-surface proteins. Finally, biotin labeled cell-sur-
face proteins were eluted from the column using DTT solution and 
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SDS–PAGE buffer and analyzed by Western blot analysis. Biotin 
labeled cultures were also fixed and labeled with a fluorescent-
conjugated streptavidin (catalogue no. 21832) from Invitrogen 
(Carlsbad, CA) to confirm that biotin labeled cell surfaces.
Immunofluorescence
Immunostaining of epithelial explants was performed as previously 
described (Walker et al., 2007, 2010). Briefly, prior to immunostain-
ing, explants were fixed in 3.7% formaldehyde in phosphate-
buffered saline (PBS) and permeabilized in 0.25% Triton X-100 
(Sigma-Aldrich) in PBS. For immunostaining of nonpermeabilized 
cells to detect only surface proteins cultures were fixed with either 1 
or 2% methanol-free paraformaldehyde, as indicated. The following 
primary antibodies were used for the immunofluorescence studies 
(see Table 1): vimentin (H5 and AMF17b mAb; Developmental Stud-
ies Hybridoma Bank, Iowa City, IA), vimentin polyclonal antibody (a 
generous gift from Paul FitzGerald), vimentin polyclonal antibody 
(catalogue no. ab92547) from Abcam (Cambridge, MA), CD44 
(1D10 mAb, Developmental Studies Hybridoma Bank, Iowa City, 
IA), tenascin-C (catalogue no. AB19013) from Millipore (Burlington, 
MA), pSerine 38 vimentin rabbit (catalogue no. ab115150), αSMA 
(catalogue no. ab5694), and citrulline antibody (catalogue no. 
ab6464) from Abcam (Cambridge, MA), and a citrulline antibody 
F95 (catalogue no. MABN328) from MilliporeSigma (Burlington, 
MA). Cells were incubated with primary antiserum followed by 
rhodamine-conjugated (Jackson ImmunoResearch Laboratories and 
Millipore), fluorescein-conjugated (Jackson ImmunoResearch Labo-
ratories, Westgrove, PA), or Alexa Fluor 488–conjugated (Thermo-
Fisher, Waltham, MA), secondary antibodies. As indicated, cells 
were counterstained with Alexa Fluor 488–conjugated phalloidin, 
Alexa Fluor 633 or Alexa Fluor 647 phalloidin (ThermoFisher, 
Waltham, MA) to label filamentous actin (F-actin), and/or the nuclear 
stain TO-PRO 3 (Invitrogen, Carlsbad, CA). To track the fate of CD44 
leader cells to become myofibroblasts, cultures were live labeled 
with CD44 antibody for 20 min. Antibody was removed and media 
was replaced for 2 d subsequent to fixation and processing for im-
munostaining. Immunostained samples were examined by confocal 
microscopy (LSM 510, LSM 800 with Super Resolution Airyscan, 
Zeiss, Thornwood, NY). Single images or Z-stacks were collected 
and analyzed; the data presented represent single optical planes or 
maximal intensity projection images.
Proximal ligation assay
To determine whether vimentin was citrullinated, we performed 
proximal ligation assay (PLA) according to manufactures guidelines 
(Duolink; Sigma-Aldrich). Briefly, fixed cultures were incubated with 
antibody to citrulline (catalogue no. ab6464) from Abcam and vimen-
tin antibody H5 from Developmental Studies Hybridoma Bank simul-
taneously, followed by PLA affinity probes for rabbit and mouse 
(Duolink; Sigma-Aldrich) that binds to the target antibodies. Cells 
were then incubated with Detection Reagents Red (Duolink; Sigma-
Aldrich), which includes a ligation solution and a connecter oligonu-
cleotide that hybridizes to the probes that allows amplification of 
DNA to produce a signal to be detected by fluorescence imaging.
Cross-link extraction
To examine whether vimentin associated with the extracellular ma-
trix deposited beneath the cells on the substrate, we performed 
cross-link extractions as previously described (Enomoto et al., 1993). 
Cells were then incubated with the cell-impermeable cross-linker 
BS3 (ThermoFisher, Waltham, MA) in PBS with phenylmethylsulfonyl 
fluoride (PMSF) protease inhibitor (Sigma-Aldrich). The reaction was 
quenched with (50 mM Tris-HCl), and the cells were extracted with 
RIPA buffer containing protease/phosphatase inhibitor cocktail (Cell 
Signaling, Danvers, MA) and the substrate-associated proteins fixed 
with 3.7% formaldehyde in PBS.
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